Sukhtian Ghiath M.'s Form 4 filing
Outlook Therapeutics, Inc. (OTLK) · filed Aug 14, 2026
- Accession no.
- 0000899140-26-000894
- Filed
- Aug 14, 2026, 7:52 PM ET
- Trade date
- Aug 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $2.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sukhtian Ghiath M.CIK 0001717441 | Director, 10% Owner |
| GMS Ventures & InvestmentsCIK 0001804598 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | PPurchaseAcquired | +2,525,252 | $0.99 | +$2,499,999.48 | 24,617,320 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | PPurchaseAcquired | +2,525,252 | $0.00 | $0 | 2,525,252 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.